This episode examines whether unprocessed red meat has a causal role in (1) type 2 diabetes risk and intermediate measures of glucose intolerance (insulin resistance, beta cell dysfunction, glycemic markers) and (2) cardiovascular disease (CVD) risk.

While there is commonly observed risk signal from observational cohorts, there exist short-term randomized controlled trials (RCTs) that show largely null effects on glucose homeostasis. This had led to differing opinions and interpretations of the evidence base.

Some feel that in the context of an otherwise healthy diet, there isn't much to suggest concern about consuming unprocessed red meat. While others are of the view that there does exist a risk and that limiting or even avoiding consumption is prudent.

The crucial concept of replacement effects is discussed. Increasing red meat intake always means decreasing something else or increasing total energy intake. Therefore, interpreting evidence requires specifying the comparator food(s), the background dietary pattern, the dose, the cut (lean vs fatty), and how the meat is prepared.

To discuss their interpretations of this contentious evidence base, Dr. Mario Kratz and Dr. Gil Carvalho join the podcast to go through the studies most directly related to these questions.

• [06:20] Red meat's impact is debated
• [10:54] Mechanisms linking meat to diabetes
• [15:31] Cohort evidence on diabetes risk
• [24:43] Differences between cohorts and threshold effects
• [33:13] RCT evidence and substitution trials
• [45:49] Why comparator foods matter
• [50:43] RCT examples and mixed results
• [01:00:30] Is there cardiovascular risk beyond saturated fat?
• [01:08:10] Epidemiology patterns and dose thresholds
• [01:11:36] Personal recommendations and risk tolerance
• [01:16:19] Key ideas

• Go to episode page (study links, guest bios, additional resources)
• Join the Sigma email newsletter for free
• Subscribe to Sigma Nutrition Premium
• Enroll in the next cohort of our Applied Nutrition Literacy course
• Mario's YouTube channel: Nourished By Science
• Gil's YouTube channel: Nutrition Made Simple!

This episode examines how exercise and nutrition interact to influence glycaemic control, with particular focus on the postprandial period (i.e., the hours after eating) and on "time-efficient" exercise strategies such as low-volume interval training.

Dr. Jenna Gillen outlines the physiological basis for why muscle contraction can acutely reduce post-meal glucose excursions, why repeated sessions can accumulate into longer-term improvements in insulin sensitivity, and why the nutrition context (pre- and post-exercise feeding, carbohydrate availability, and energy balance) can meaningfully alter observed outcomes.

A key translational thread is that many clinically relevant improvements may come from small, feasible doses of activity; especially post-meal walking and brief "exercise snacks" used to interrupt sedentary time.

However, the discussion considers who these interventions matter for most (and least). Postprandial glucose rises are normal in healthy individuals, whereas reducing exaggerated excursions is most relevant for those with insulin resistance, prediabetes, or type 2 diabetes (T2D).

Dr. Jenna Gillen is an Assistant Professor of Exercise Physiology in the Faculty of Kinesiology & Physical Education at the University of Toronto.

• [02:42] Dr. Gillen's research focus
• [04:11] Understanding glycemic control
• [10:07] Fasted vs. fed state exercise
• [11:10] Post-meal exercise benefits
• [20:10] Low volume interval training
• [26:27] Interval training and blood glucose
• [31:29] Energy balance and insulin sensitivity
• [36:32] Exercise and nutrition interactions
• [40:11] Practical exercise recommendations
• [43:56] Key ideas segment (Premium-only)

• Go to episode page (with links to papers)
• Join the Sigma email newsletter for free
• Subscribe to Sigma Nutrition Premium
• Enroll in the next cohort of our Applied Nutrition Literacy course
• See Sigma's recommended resources

In clinical practice effective nutrition, exercise, and obesity care is rarely about identifying the single "best" plan on paper. Instead, sustainable change depends on behavioral psychology: understanding the person's context, motivation, barriers, and patterns, then co-designing practical steps that can actually be implemented in real life.

David Creel PhD, RD is a clinical psychologist and registered dietitian working in weight management at the Cleveland Clinic. Dr. Creel discusses how clinicians can bridge the gap between "optimal recommendations" and what is most likely to create actual behaviour change. This includes a combination of using collaborative communication, self-monitoring, skill-building, relapse prevention planning, and a multidisciplinary framework.

Behavioral and psychological factors shape food choices, physical activity, and adherence far more than knowing the newest guideline. In addition, the modern obesity treatment landscape (including GLP-1 receptor agonists) increases the need for structured behavior-change support: people may experience new hope and new fear (especially fear of weight regain), and the key clinical question becomes how to use these tools to build durable habits and reduce relapse risk over the long term.

• [03:09] Start of interview
• [05:31] Challenges in nutrition and exercise recommendations
• [11:01] Behavior change in real-world practice
• [16:32] Self-monitoring and its importance
• [23:48] Non-scale victories and positive body image
• [25:58] Focusing on body capabilities over aesthetics
• [27:20] Integrating activity into lifestyle
• [30:30] Exercise snacking and practical tips
• [33:36] Impact of GLP-1 receptor agonists
• [38:24] Addressing fear of weight regain
• [41:24] Effective multidisciplinary obesity treatment

• Go to episode page
• Join the Sigma email newsletter for free
• Subscribe to Sigma Nutrition Premium
• Enroll in the next cohort of our Applied Nutrition Literacy course
• LinkedIn:
  • Dr. David Creel
  • Danny Lennon
• X/Twitter:
  • @drdavidcreel
  • @NutritionDanny